CVS Health Corporation’s stock (NYSE:CVS) has been rated as Outperform by RBC Capital Mkts. This latest rating was contained in a recent research note published by the firm on September 27, 2019 and has set a $85 price target for the stock. Some experts on Wall Street have also posted a report on CVS Health Corporation (CVS) stock.
Deutsche Bank rated the stock as a Buy in a research noted published on September 12, 2019. Standpoint Research rated the stock as a Buy in a research note published on June 05, 2019.
As it stands, a total of 27 analysts are covering CVS stock, with 17 of them rating it as a Buy while 2 of them rating it as Overweight. 8 analysts meanwhile advised investors to Hold, 0 rated it as Underweight while the 0 rated it as a Sell. A look at the overall ratings means that CVS Health Corporation (CVS) stock has an average rating of Overweight.
CVS Health Corporation (CVS) which is currently valued at 98.94 billion, with the company publishing its last earnings report on 11/06/2019, for the recent quarter of 2019. In that quarter, the company recorded a revenue of 63.97 billion, which was lower than the forecast of 65.35 billion made by some analysts. For that same quarter, CVS Health Corporation (CVS) posted $2.14 earnings per share (EPS) which was above the analyst consensus estimate of $2.05 by $0.09, which represents an increase by 4.40%.
The stock market has a tendency to become sophisticated sometimes, even for seasoned investors and traders. Even when a trader got what he/she had expected, the market sometimes decides to move in the opposite direction. This volatility sometimes leads to some traders doubting and second-guessing their moves. This is why getting to know historical price performance, as well as both long-term and short-term trends, is very important. Over the past one week, CVS price has surged by 3.59%. A look at its price performance over the past three months sees the stock go up by 16.10%, while it has gain 33.86% over the past six months and 18.09% since the start of the year.
Let us now look at some of its likely support and resistance level. Recent research on CVS Health Corporation (CVS) has seen its stock trading -2.28% below its three-month high price. A look at the other side also sees stock trading +16.92% above its three-month low. A wider look sees CVS trading -2.28% below its 52-week high and 45.53% above from its 52-week low price.
Shareholders of the company sometimes like to find out how their investments are growing. CVS Health Corporation (CVS) has so far given an ROE of 7.40%. When the ROE is low, it means that the company isn’t generating enough profits. The Return on Assets (ROA) ratio meanwhile is an indication of how profitable a company is relative to the total asset it owns. CVS Health Corporation (CVS)’s ROA at the moment stands at 2.10%. Any company that is managing its assets better will have a higher return while one that manages assets poorly would result in low returns.
CVS Health Corporation (CVS) has a return on investment (ROI) of 1.50%. The higher the ROI percentage, the higher the profit exceeds the costs, thus analysts consider such investments as an overall gain. A negative ROI, however, means that the cost is higher than the profits, a scenario analysts consider as a net loss.
Let us now take a look at CVS Health Corporation (CVS)’s trading volatility. Its 7-day volatility is around 1.82%, while it has a monthly volatility of 1.40%. CVS has an ATR (Average True Range) of 1.19 and a beta factor of 0.90. The volatility of a stock is an indication of the stock’s drop or gain in case the wider market drops or surges. A beta score higher than 1 means that a stock is highly volatile while below 1 means that the volatility of a stock is low.
The price of CVS lifted by $1.44 during the normal trading session on Wednesday to trade at $75.27. The CVS Health Corporation (CVS) stock has a trading volume of 8.07 million shares, which is high, compared to its average daily volume of 6.65M shares.